fatty liver and semaglutide effectively treats disease in two thirds of patients, research finds Semaglutide (Wegovy) Improves MASH in
Description
Quick Answer: Semaglutide does not cause clinically significant liver damage in most patients and may improve liver health markers through weight loss effects
Investigation The patient came to our observation in January 2020
[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Collins L, Costello RA
Kidney function should be monitored periodically, especially in patients with pre-existing kidney conditions
